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Abstract
Background: Cronobacter spp. is a newly emerging pathogen that causes meningitis in infants and other diseases
in elderly and immunocompromised individuals. This study was undertaken to investigate surface antigenic
determinants in Cronobacter spp. using monoclonal antibodies (MAbs) and MALDI-TOF Mass spectrometry.
Results: Spleenocytes from mice that were immunized with heat-killed (20 min, 80°C) Cronobacter cells were fused
with SP2 myeloma cells. Five desirable MAbs (A1, B5, 2C2, C5 and A4) were selected. MAbs A1, B5, 2C2 and C5
were of IgG2a isotype while A4 was an IgM. Specificity of the MAbs was determined by using immunoblotting
with outer membrane protein preparations (OMPs) extracted from 12 Cronobacter and 6 non-Cronobacter bacteria.
All MAbs recognized proteins with molecular weight ranging between 36 and 49 kDa except for one isolate (44) in
which no OMPs were detected. In addition, MAbs recognized two bands (38-41 kDa) in four of the non-
Cronobacter bacteria. Most of the proteins recognized by the MAbs were identified by MALDI-TOF peptide
sequencing and appeared to be heterogeneous with the identities of some of them are still unknown. All MAbs
recognized the same epitope as determined by an additive Index ELISA with their epitopes appeared to be
conformational rather than sequential. Further, none of the MAbs recognized purified LPS from Cronobacter spp.
Specificity of the MAbs toward OMPs was further confirmed by transmission electron microscopy.
Conclusions: Results obtained in this study highlight the immunological cross-reactivity among Cronobacter OMPs
and their Enterobacteriaceae counterparts. Nevertheless, the identity of the identified proteins appeared to be
different as inferred from the MALDI-TOF sequencing and identification.
Background
Cronobacter spp. (formerly Enterobacter sakazakii)i s
a non-spore forming, motile, facultative anaerobic Gram-
negative bacillus and belongs to family Enterobacteriaceae
[1,2]. Initially isolates of Cronobacter spp. (Cronobacter)
were identified as yellow pigment producing Enterobacter
cloacae. Later, Farmer et al., [3] reclassified them as a new
species and were given the name sakazakii based on
DNA-DNA homology, antibiotic susceptibility patterns
and certain unique biochemical characteristics such as cat-
alase production, the absence of oxidase and the produc-
tion of yellow pigment in all tested strains.
More recent studies utilizing full length 16S rRNA
gene sequencing, ribotyping, fluorescent-amplified frag-
ment length polymorphism and DNA-DNA hybridiza-
tion have demonstrated that Cronobacter is a
heterogenic genus exhibiting a high degree of genetic
and phenotypic diversity among species and comprises
six species: C. muytjensii, C. sakazakii, C. malonaticus,
C .t u r i c e n s i s ,C .d u b l i n e n s i sand C. genomospecies I
[4-7]. Cronobacter is considered an emerging pathogen;
though, little is known about its virulence properties
and antigenic determinants [8]. Recently, several studies
have reported the involvement of an outer membrane
protein (OMP), OmpA, in pathogenesis of C. sakazakii;
however, nothing is known about its antigenicity.
Besides, little is known about OMPs from other Crono-
bacter species [8-10]. In contrast, the virulence and anti-
genic properties of OMPs of closely related Enterobacter
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[12,13] were studied well.
Prematurely born infants with low birth weights and
infants in neonatal intensive care units are highly sus-
ceptible to Cronobacter infections with the pathogen
being transmitted primarily from contaminated environ-
ments to the infant formula during the preparation
[14-20]. In rare cases, nosocomial infections can happen
in adults especially in immunocompromised ones [21].
In 2004, a joint FDA/WHO workshop raised an alert
concerning the presence of Cronobacter in powdered
infant formula (PIF) and recommended applying higher
microbiological standards during its manufacturing [22].
This warning culminated into increased research efforts
to study Cronobacter including the development of
improved isolation and identification methods, and
understanding of the growth and survival characteristics.
Antibodies are the most frequently used tools to study
bacterial antigenic determinants; however, little is known
about the production of monoclonal antibodies that
recognize Cronobacter antigenic determinants. In this
paper we describe the production and characterization of
5 MAbs that recognize outer membrane proteins of Cro-
nobacter. In addition, antigenic properties, identification,
distribution and cell surface localization of the MAbs-
recognized OMPs were examined using electron micro-
scopy and MALDI-TOF spectrometry. To our knowl-
edge, this is the first report on using monoclonal
antibodies to study the surface antigens of this pathogen.
Methods
Materials
Alkaline phosphatase-conjugated goat anti-mouse immu-
noglobulin, complete Freund’s adjuvant, incomplete
Freund’s adjuvant, sarkosyl, DMSO, pancreatic RNase
and DNase and a mouse subisotyping kit were from
Sigma-Aldrich, USA. Gold-conjugated (18 nm) anti-
mouse IgG was obtained from Jackson Immunochem-
icals, USA. Polyethelyene glycol 4000 was from Fluka,
USA. Micro test plates, tissue culture plates and flasks
were from Griener, Germany. Coommassie Brilliant blue
G-250 was from BDH chemicals, Ireland and BSA was
from Biobasic, Canada; Proteinase K was from Promega,
USA. Goat anti-mouse-conjugated to horse radish perox-
idase (HRP) was from Santa Cruz, USA. Penicillin, strep-
tomycin and amphotercin B were from PAA Laboratories
GMBH, Austria. Recovery cell culture freezing media was
from Gibco, USA. Myeloma SP2 cells were a gift from
Dr. Khalid Qaoud, Yarmouk University, Jordan. All other
chemicals and reagents were of analytical grade.
Bacteria and growth conditions
Stock cultures were maintained through out this study
on Trypticase Soy Agar (TSA) (Oxoid, UK) or nutrient
agar plates (HiMedia, India) at 4°C until use. The type
strain C. muytjensii ATCC 51329 was grown overnight
at 37°C in nutrient broth (NB) (HiMedia). Cells were har-
vested by centrifugation (5,000 × g, 10 min), washed twice
with 0.1 M PBS (pH 7.2) and adjusted to 10
8 CFU ml
-1
using McFarland standard. Bacterial cells were heated at
80°C for 20 min in a water bath and were subsequently
used for immunization of mice and screening of hybri-
doma cells for MAbs production using ELISA. Several
Cronobacter strains used in the study were isolated from
Jordan (Table 1). These isolates were identified and char-
acterized by several traditional and molecular methods
[19]. The 16S rRNA sequences of the isolates were depos-
ited in the GenBank (MD, USA) (Table 1), while the iso-
lates were deposited in the Egyptian Microbial Culture
Collection (Ain Shams University, Cairo, Egypt).
Lipopolysaccharide (LPS) extraction and antigen
preparation
LPS was prepared following the method described by Jar-
adat and Zawistowski [23], with minor modifications.
Briefly, C. muytjensii ATCC 51329 cells were harvested
from an overnight culture by centrifugation (5,000 × g,
10 min) and resuspended in 50 ml of 50 mM sodium
phosphate buffer, pH 7.0. The cells were sonicated 5
times for 45 s intervals at 300 Watts (Branson Sonifier).
The sonicated suspension was incubated with pancreatic
RNase and DNase (0.1 μgm l
-1) in 20 mM MgCl2 at 37°C
for 10 min, followed by 10 min at 60°C and then mixed
with an equal volume of preheated 90% phenol. Follow-
ing incubation (70°C for 15 min) with occasional mixing,
the mixture was centrifuged (18,000 × g, 1 h) and the
resulting aqueous layer was collected and dialyzed using
dialysis tubing of 6,000-8,000 MW cutoff at room tem-
perature against several changes of distilled water until
no detectable phenol odor remained. The dialysate was
treated with 20 μg/ml of Proteinase K in 0.1 M Tris-HCl
(pH 8.0) at 60°C for 1 h followed by overnight incubation
at 37°C. The samples were then lyophilized and stored at
-20°C until used. For antigen preparation, the extracted
LPS from Cronobacter was mixed (1:1) with 30% (w/v)
polyacrylamide solution; ammonium persulfate (50 μl)
and TEMED (10 μl) were added to the mixture to obtain
a 15% polyacrylamide gel (v/v) [24]. The gel-containing
LPS was frozen in liquid nitrogen and ground with a pes-
tle and mortar into a fine powder. The powder was dis-
solved in 10 ml PBS (0.1 M, pH 7.0) and immediately
used for immunization [25].
Outer membrane protein extraction
OMPs were extracted using the sarkosyl-based method
described by Davies et al., [26]. Briefly, Cronobacter cells
were harvested from overnight cultures by centrifugation,
and then treated with 0.1 μg of bovine RNase and DNase
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sonicated for 10 min in 45 sec intervals at 300 watts on
crushed ice and were centrifuged (5,000 × g for 30 min at
4°C). The supernatant was collected and re-centrifuged
(29,000 × g for 2 h at 4°C). The resulting pellet was treated
with 10 ml of 2% (w/v) sarkosyl for 30 min at room tem-
perature. The mixture was centrifuged (29,000 × g for 2
h). The resulting pellet was washed with 10 ml of 20 mM
Tris-HCl (pH 7.7) containing 2% (w/v) SDS and re-centri-
fuged (29,000 × g for 2 h at 4°C). The final pellet, which
contained OMPs, was resuspended in distilled water, ali-
quoted and stored at -20°C for further use.
Production of monoclonal antibodies against Cronobacter
spp
Female Balb/c mice (6 to 8 weeks old) were initially
immunized intraperitoneally with 200 μl( 1 0
8 CFU ml
-1)
of heat-killed bacterial suspension (C. muytjensii ATCC
51329) mixed with complete Freund adjuvant at a 1:1
ratio. Subsequently, 4 booster doses were administrated
at weekly intervals using the same amount of immuno-
gen but prepared with incomplete Freund adjuvant.
Simultaneously, female Balb/c mice (6 to 8 weeks old)
were immunized intraperitoneally with 200 μl of polya-
crylamide-LPS preparationi nP B Sf o ra tl e a s t8w k sa t
weekly intervals. Myeloma SP2 cells were maintained in
RPMI media supplemented with 10% Fetal Calf Serum
(FCS), 20 U of penicillin, 20 U streptomycin and 2.5 μg
ml
-1 amphotercin B. At the day of fusion, the actively
grown myeloma culture was washed twice using serum-
free media (SFM) and adjusted to the desired concentra-
tion. The fusion was performed according to the
method described by Liddell and Cryer [27] using 40%
(w/v) polyethylene glycol 4000 as the fusing agent in
sterile SFM adjusted to pH 7.4. Spleen cells harvested
from immunized mice and myeloma cells were fused at
a ratio of 8:1. Two weeks later, hybridomas were
screened for the production of MAbs by ELISA using
heat killed Cronobacter and non-Cronobacter cells.
Hybridomas reacting specifically with Cronobacter were
expanded and cloned at least three times by limiting
dilution. Positive clones were frozen in recovery cell cul-
ture freezing media
® or FCS supplemented with 4% (v/
v )D M S Oa n ds t o r e da t- 8 0 ° Co v e r n i g h tb e f o r eb e i n g
transferred to liquid nitrogen. The positive clones were
propagated either in tissue culture or by ascitic fluid
using the procedure of Harlow and Lane [28]. Isotypes
of purified monoclonal antibodies from ascites or spent
medium were determined using the mouse type subiso-
typing kit according to the manufacturer’s instructions.
Table 1 Cronobacter and Non-Cronobacter strains used in this study
Isolate # Isolate identity Source Isolate ID GenBank ID based on 16S rRNA sequence
- C. muytjensii - ATCC 51329 -
C4 C. sakazakii Clinical -
C6 C. sakazakii Clinical CDC 407-77 -
C13 C. sakazakii Clinical ATTC 29004 -
Jor* 44 C. sakazakii Food EMCC 1904 FJ906902
Jor* 93 C. sakazakii Food EMCC1905 FJ906906
Jor* 112 C. muytjensii Food EMCC1906 FJ906909
Jor* 146A C. sakazakii Food EMCC1907 FJ906897
Jor* 146B C. sakazakii Food EMCC1908 FJ906910
Jor* 149 C. muytjensii Food EMCC1909 FJ906912
Jor* 160A C. sakazakii Environment EMCC1910 FJ906914
Jor* 170 C. turicensis Food EMCC1912 FJ906916
None -Cronobacter
- C. freundii - ATCC 43864 -
- E. coli - ATCC 35218 -
- L. ivanovii - ATCC 19119 -
- P aeruginosa - ATCC 27833 -
- S. enterica Choleraesuis - CIP 104220 -
- S. sonnei - ATCC 9290 -
Jor*: Strains were isolated from food and environmental samples collected in Jordan and were deposited in the Egyptian Microbial Culture Collection (EMCC; Ain
Shams University, Cairo, Egypt) and their 16S rRNA sequences were deposited in the GenBank. C: clinical samples isolated from patients obtained from CDC
(Atlanta, GA, USA) and were a gift from Dr. Ben Davies Tall from U.S. FDA. All the other isolates were obtained from the American Type Culture Collection (ATCC)
except for Salmonella which obtained from the Collection of Institute Pasteur (CIP) and S. sonnei which was a local strain.
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Elisa
Screening of antisera spent medium and ascites for the
presence of antibodies against Cronobacter was per-
formed by an indirect non-competitive ELISA. Flat-bot-
tom 96 well plates were coated with 0.1 ml of (10
8 heat-
killed cells ml
-1) of whole cell antigen diluted in 0.05 M
carbonate buffer (pH 9.6) overnight at 4°C. Alkaline
phosphatase-conjugate goat anti-mouse immunoglobulin
and p-nitrophenyl phosphate were used as secondary
antibodies and substrate, respectively.
Additive index elisa
Additive index ELISA was performed on paired MAbs as
described by Friguet et al., [29]. An additive index for
each pair of MAbs was calculated according to the for-
mula {[2A1+2/(A1 + A2)] - 1} × 100, where A1, A2,a n dA1
+2 are absorbance values with antibody 1 alone, antibody
2 alone, and the two antibodies together, respectively.
Gel electrophoresis
Profiles of Cronobacter OMPs were examined using
SDS-PAGE following the method described by Laemmli
[30]. The runs were performed in 4% stacking and
12.5% separating gels. Equal concentrations of Crono-
bacter OMPs (20 μgw e l l
-1) were mixed with sample
buffer at a ratio of 1:5, boiled for 5 min and loaded
(approx. 20 μl/lane). Gels were either stained with 1%
(w/v) Coommassie Brilliant Blue G-250 or used for
immunoblotting. Likewise, LPS preparations from Cro-
nobacter were examined using Deoxycholate-polyacryla-
mide gel electrophoresis (DOC-PAGE) following the
method described by Reuhs et al., [31]. Briefly, the runs
were performed using 4% (v/v) stacking and 12.5% (v/v)
separating gels. Equal concentrations of Cronobacter
LPS (5 μgw e l l
-1) were mixed with sample buffer [2 ml
of 22.7% (w/v) Tris-base solution; 1 ml of 50% (v/v) gly-
cerol; 1 ml of 1% (w/v) bromophenol blue and 6 ml dis-
tilled water] at a ratio of 1:5. The gels were pre-run in
DOC-electrophoresis buffer (Tris-base, 4.5 g; glycine,
21.7 g; 2.5 g sodium deoxycholate, pH adjusted to 8.3
and volume adjusted to 1 liter) for 10 min at 80 volts
before loading the samples. Samples were run in the
same buffer at 80 and 120 volts for the stacking and
separating gels, respectively. Upon completion, gels were
either stained using the PageSilver™ silver staining kit
(Fermentas) or were used for immunoblotting. Band
sizes for both gels and blots were estimated using the
BioRad Quantity One 1-D Analysis Software.
Immunoblotting
Immediately after completing the electrophoresis run,
OMPs and LPS were transferred to nitrocellulose (NC)
membranes according to Harlow and Lane [28] with
some modifications. Gels and NC membranes were
soaked in Tris-glycine transfer buffer (10% [v/v] metha-
nol, 24 mM Tris base, 194 mM glycine) for 15 min.
Separated OMPs and LPSs were transferred onto NC
using a mini-transblot cell (Bio-Rad). The membranes
were blocked with 3% (w/v) BSA in Tris Buffered Saline
(TBS) containing Tween 20 (0.05% v/v). NC membranes
were then incubated with affinity purified MAbs (2 μg
ml
-1) diluted in 0.15 M TBS buffer containing 1% (w/v)
BSA with gentle shaking for 1 h. Membranes were then
developed with goat anti-mouse-HRP in 0.15 M TBS
buffer containing 1% (w/v) BSA and a diaminobenzidine
(DAB) substrate solution. Color development was
stopped by rinsing the membranes with distilled water.
Protein sequencing and identification
Extracted OMPs were separated on SDS-PAGE gels and
probed with anti-OMP monoclonal antibodies. Immuno-
blot-positive bands were cut with sterile sharp scalpel
and immersed in 1% acetic acid solution. Protein
sequencing was performed using the MALDI-TOF tech-
nology at the Proteomics and Mass Spectrometry Facil-
ity at Purdue University (West Lafayette, Indiana, USA).
Dot blot assay
Dot blotting was performed as described by Jaradat and
Zawistowski [23]. One microliter of heat-killed Crono-
bacter whole-cell suspension (10
8 cells ml
-1) was spotted
on the NC membranes, allowed to air dry for 30 min
and incubated in 5% (w/v) NaOH or in 38% (v/v) HCl
for 10 s or left untreated. Immunoblotting was per-
formed as described above.
Immunoelectron microscopy
Immunolabeling was performed essentially as described
by Jaradat and Zawistowski [23] with modifications.
Briefly, 5 μl of bacterial suspension in distilled water (5
×1 0
8 CFU ml
-1) were placed on formvar-coated copper
grids. After air-drying for 2 h at room temperature, the
grids were blocked with PBS containing 3% (w/v) BSA
for 30 min at 37°C. To expose antigens on bacteria,
grids were incubated with 0.1 M NaOH or 0.1 M HCl
for 2 h, washed with water and incubated with purified
MAb solution at 37°C. Grids were then incubated with
colloidal gold (18 nm)-conjugate anti-mouse IgG diluted
at 1:50 in dilution buffer (0.02 M Tris, 150 mM NaCl,
0.1% [w/v] BSA, 0.005% [v/v] Tween 20, 0.4% [w/v]
gelatin [pH 9]) for 20 h at room temperature. Grids
were washed 6 times with water and viewed with a
Zeiss Transmission Electron Microscope at various
magnifications.
Animal use
Animals used for immunization and production of
monoclonal antibodies were cared for according to the
Animal Care and Use Committee (ACUC), Jordan Uni-
versity of Science and Technology.
Results
Two approaches were attempted to produce monoclonal
antibodies specific to Cronobacter spp.: one group of
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ATCC 51329, while the other group was immunized
with LPS purified from C. muytjensii ATCC 51329.
Repeated immunization with the LPS produced a good
antibody response as judged from both ELISA and
immunoblotting results using antisera from LPS-immu-
nized mice which revealed the characteristic ladder pat-
tern of LPS (Figure 1). However, none of the two
immunization protocols resulted in a stable hybridoma
producing anti-LPS antibodies. Nevertheless, mice
immunized with heat-killed cells responded well yielding
a high titer after 5 injections. Consequently, mice from
this group were sacrificed and two fusions were per-
formed yielding over 500 hybridomas of which approxi-
mately 180 clones were positive upon initial screening
and were cloned 3 times by limiting dilution [32-34]. Of
these, only 5 stable hybridomas secreted antibodies
against Cronobacter spp. Four of the hybridomas were
of IgG type (A1, B5, 2C2 and C5), while the last hybri-
doma (A4) was of the IgM class. The avidity of the
MAbs to their epitopes was determined by ELISA. The
t i t r a t i o nc u r v ef o ra l lp r o t e i nG - c o l u m np u r i f i e dM A b s ,
except for A4, revealed that MAb-2C2 had the highest
avidity followed by C5, B5 and A1 having the lowest.
MAb A4, an IgM, was not tested as it was not purified
by Protein G column affinity chromatography.
Specificity of the monoclonal antibodies
The specificity of the MAbs was determined by non-
competitive ELISA with various heat- killed bacteria
belonging to Cronobacter and non-Cronobacter spp. In
general, all MAbs reacted with both Cronobacter and
non-Cronobacter spp. with higher titers generally
obtained for Cronobacter spp. (Titer of 3200 Cronobac-
ter versus 400 for some non-Cronobacter). Nevertheless,
some non-Cronobacter spp. also gave titers comparable
to those obtained for Cronobacter (Titer 3200). The
binding affinities varied among the four MAbs with
MAbs 2C2 and C5 gave titers of 3200 against almost all
the heat-killed Cronobacter strains tested, whereas
MAbs A1 and B5 had titers ranging between 800 to
more than 6400.
Figure 1 DOC-PAGE (left panel) and immunoblotting (right panel) for LPS extracted from C. muytjensii ATCC 51329 (lanes A and A1)
and E. coli (lanes B and B1). Blots were probed with mouse antisera collected after immunization with LPS preparation from C. muytjensii
ATCC 51329.
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purified MAbs was tested against OMPs extracted from
12 Cronobacter and 6 non -Cronobacter strains by SDS-
PAGE followed by immunoblotting.
SDS-PAGE profiles of both Cronobacter and non-Cro-
nobacter revealed the presence of several proteins with
molecular weights ranging from 12 to 100 kDa (data not
shown) with the majority of OMPs profiles contained 3
to 5 major proteins having molecular weights between
34 and 55 kDa. Upon immunoprobing, all MAbs pro-
duced similar reaction profile of proteins with molecular
weights between 36 to 49 kDa with only one major
band for all Cronobacter OMP profiles except isolate
Jor44 which did not exhibit any protein (Figure 2, lane
7, C. sakazakii, lower panel). In general, the 36 kDa pro-
tein was the most common among all Cronobacter OMP
profiles. It was detected by immnunoblotting in 5 out of
the 12 tested Cronobacter strains (Figure 2, lower panel;
lanes, 5, 6, 9, 10, 11; C. sakazakii, C. turicensis, C. saka-
zakii, C. sakazakii, C. muytjensii, respectively), and a 42
kDa protein was detected in two C. sakazakii isolates
(Figure 2, lower panel; lanes, 1 and 12), while a 41 kDa
protein was detected in two isolates (C. sakazakii,a n d
C. muytjensii, lower lanes 4 and 8 respectively). In addi-
tion, proteins of 37 and 39 kDa were detected each in
one C. sakazakii isolate (Figure 2, lower panel; lanes 2
and 3, respectively). OMPs from a number of non-Cro-
nobacter species were also tested for reactivity against
the purified MAbs by immunoblotting. Unlike the single
band pattern observed in Cronobacter OMP immuno-
blot profiles, the non-Cronobacter immunoblot profiles
exhibited a double-band pattern corresponding to MW
of 38 and 41 kDa (Figure 3 lower panel; lanes 3, 4, 6
and 7 representing strains; E. coli, P. aeroginusa,
Salmonella,a n dS. sonnii respectively). In addition, C.
freundii (Figure 3 lower panel; lane 2) exhibited only
one protein corresponding to 40 kDa, while the only
Gram-positive control strain (L. ivanovii,l a n e5 )e x h i b -
i t e dt h es a m et w ob a n d sw i t hah i g h e rM W( 3 9a n d4 2
kDa) than those which appeared in samples from the
Gram-negative isolates. In order to determine which
surface antigen the MAbs were bound to, OMPs and
LPS extracted from Cronobacter muytjensii ATCC
51329 (strain used for immunization) were analyzed by
SDS-PAGE, DOC-PAGE and immunoblotting. All
M A b s( A 1 ,B 5 ,2 C 2 ,C 5a n dA 4 )d i s p l a y e ds t r o n ga n d
specific reaction against a 44 kDa OMP (Figure 4).
Although these MAbs were produced from two different
fusion experiments, they all reacted strongly and specifi-
cally against the same 44 kDa OMP. Furthermore, to
compare the epitope specificity of all MAbs, additive
index ELISA was conducted for each pair of the MAbs.
All scores obtained were very low and fall in the range
of 0 to 10 indicating that all MAbs were raised against
the same epitope within the 44 kDa OMP.
Protein identification by MALDI-TOF peptide sequencing
Representatives of the immunoblot-positive proteins
were subjected to peptide sequencing and identification
using MALDI-TOF Mass spectrometer. Table 2 shows
the identified proteins by MALDI-TOF. The 44 kDa
protein that was recognized by all the monoclonal anti-
bodies in C. sakazakii appeared to be a novel protein
that did not match with any identified protein thus was
termed a hypothetical protein.
In addition, the 35 kDa protein identified in the Cro-
nobacter isolate 146A also appeared to be a novel pro-
tein termed a hypothetical protein that did not match
Figure 2 SDS-PAGE (Upper) and Immunoblot (Lower) of OMPs extracted from different Cronobacter strains probed with MAb 2C2.M :
Molecular weight marker; 1: C. muytjensii ATCC 51329; 2: C4; 3: C6; 4: C13; 5: Jor93; 6: Jor170; 7: Jor44; 8: Jor112; 9: Jor146A; 10: Jor146B; 11:
Jor149; 12: Jor160A.
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tein sequence bank (Table 2). Two Cronobacter isolates
(160A and C13) exhibited a 42 kDa protein with identity
as a flagellar hook protein FlgE and an outer membrane
porin protein in the two isolates respectively. Further, a
40 kDa protein was recognized in Cronobacter isolate
112, and appeared to be an outer membrane protein F
which is similar to an outer membrane protein F in E.
coli.B o t hE. coli and Salmonella contained another
similar protein with a MW of 38 kDa and was identified
as an outer membrane protein A. In addition, both
exhibited a 35 kDa porin protein yet appeared to be
somewhat different.
Effect of different treatments of antigens on MAbs
binding affinity
To gain insights about the nature of the binding
between the MAbs and their target epitopes, ELISA and
Dot-blot were carried out using different antigens
(OMPs, heat killed bacterial cells, LPS) which were sub-
jected to different treatments (acid, alkaline, denaturing
agents and heat) (Figure 5). Acid and base-treatments of
whole cell antigens resulted in an increase in the bind-
ing affinity between the MAbs and those antigens.
These results were confirmed by immunoelectron
microscopy. Cronobacter muytjensii ATCC 51329 cells
displayed intense colloidal gold labeling after reaction
with MAb 2C2 (similar results were obtained with the
other MAbs) (Figure 6).
Finally, to determine whether the MAbs recognized
sequential (Linear) or conformational epitopes, OMPs
were either left intact or denatured by 1% (w/v) SDS
a n db o i l e df o r5m i na n dt h e nu s e da sa n t i g e n sf o r
ELISA. The magnitude of binding of MAbs to antigens
was higher for untreated OMPs than the denatured pro-
teins (Table 3). This indicates that, the epitope is con-
formational and loses its recognition sites once
denatured.
Figure 4 Immunoblot for SDS-PAGE gel of OMP extracted from C. muytjensii ATCC 51329 and probed with all MAbs.M :M o l e c u l a r
weight marker
Figure 3 SDS-PAGE (Upper) and Immunoblot (Lower) of OMPs extracted from different Non-Cronobacter strains probed with MAb 2C2.
M: Molecular weight marker; 1: C. muytjensii ATCC 51329; 2: Citrobacter freundii;3 :E. coli;4 :Pseudomonas aeruginosa;5 :Listeria ivanovii;6 :
Salmonella;7 :Shigella sonnii
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Antibodies against surface antigens of pathogens aid not
only in characterization but also in their classification
[35]. In this study monoclonal antibodies were produced
against outer membrane proteins of Cronobacter muyt-
jensii. However, we were unable to produce antibodies
against LPS. Inability to produce stable hybridomas
against LPS could be attributed to the simplicity of the
LPS structure which is a linear unbranched chain of
repeating polysaccharide units as reported by MacLean
et al., [7]. The linearity of the structure was probably
responsible for the inability to elicit a significant
immune response which was reflected on the inability to
produce monoclonal antibodies against LPS of this
strain. Luk and Lindberg [36] initially failed to produce
stable antibody-producing hybridomas against LPS of
Salmonella. Later, they succeeded when they used whole
bacterial cells coated with LPS as immunogen. Similarly,
J o n g h - L e u v e n i n ke ta l . ,[ 3 7 ]a n dJ a r a d a ta n dZ a w i s -
towski [23] were able to produce monoclonal antibodies
against LPS of Salmonella. This could be due to differ-
ences in the nature of the structure and composition of
LPS between Salmonella and Cronobacter spp. and even
among different Salmonella serovars.
In this study, the anti-OMP antibodies were charac-
terized for specificity and all 5 monoclonal antibodies
not only reacted with Cronobacter species, but also
recognized other Enterobacteriaceae. The low specificity
indicates that the major outer membrane proteins in
the family Enterobacteriaceae are perhaps well con-
served as indicated by their antigenic cross-reactivity.
The specificity of the monoclonal antibodies was further
tested using SDS-PAGE and immunoblotting. The SDS-
PAGE protein profiles for the OMPs observed in this
study were similar to those of OMPs described by other
researchers for other members of the Enterobacteriaceae
[38,39]. Overall, most of the isolates contained OMP
proteins with MW ranged from 34-55 kDa (Figure 2
upper panel) with majority of the isolates exhibiting
proteins in the range of 36-49 kDa with the 49 kDa
protein appeared in all Cronobacter species (Figure 2
upper panel). In contrast, the non-Cronobacter isolates
(Figure 3) showed slightly different protein profiles
among the Enterobacteriaceae members and even a
slight shift in the tested Gram-positive strain, L. ivano-
vii. The cross-reactivity observed among all Cronobacter
strains used in this study indicated that some of these
OMPs share common and highly antigenic epitopes.
These patterns of cross-reactivity of MAbs with OMPs
from bacterial strains within the same species are com-
monly reported especially for members of the Entero-
bacteriaceae [38-42]. On the other hand, fewer studies
have reported the production of anti-OMP MAbs within
species that were non-cross reacting and exhibiting a
high degree of specificity [43,44]. The reactivity of
MAbs to OMP and the lack of any reactivity against
LPS indicated that Cronobacter OMPs appeared to be
more antigenic than their LPS. This observation coin-
cides with several other reports in which it was demon-
strated that OMPS were stronger immunogenes than
LPS, and were responsible for producing antibodies
with higher affinities [45,46].
All MAbs tested by immunoblotting against OMPs
extracted from C. muytjensii ATTC 51329 were able to
recognize a 44 kDa protein. This protein appears to con-
tain a highly antigenic epitope capable of eliciting strong
immune response in mice against the Cronobacter strain
used in the immunization procedure. The identity of this
protein was determined by MALDI-TOF MS to be a
hypothetical outer membrane protein ESA_03699 [Enter-
obacter sakazakii ATCC BAA-894]. This protein
appeared to be dominant in this particular strain and
protruding to the surface making it highly accessible to
t h eh o s ti m m u n es y s t e m .T h es p e c i f i cf u n c t i o no ft h i s
Table 2 Protein bands identified by MALDI-TOF mass spectrometer
Band Strain Predicted MW
(kDa)
Protein annotation (NCBI database) Accession
No.
No. of peptides identified
by MS/MS
1 160A(C. sakazakii) 42 Flagellar hook protein FlgE [Shigella sonnei Ss046] gi|74311638 1
2 Escherichia coli 35 Outer membrane protein (porin) [Escherichia coli B171] gi|75211632 5
3 Escherichia coli 38 Outer membrane protein A [Escherichia coli 536] gi|110641146 7
4 Salmonella CIP 35 Outer membrane protein (porin) nmpc precursor
[Escherichia coli CFT073]
gi|26247429 6
5 Salmonella CIP 38 Outer membrane protein A [Escherichia coli 536] gi|110641146 8
6 C13(C. sakazakii) 42 P COG3203: Outer membrane protein (porin)[Escherichia
coli 101-1]
gi|83587007 1
7 112 (C. muytjensii) 40 Outer membrane protein F [Escherichia coli SMS-3-5] gi|170682361 1
8 146A (C. sakazakii) 35 Hypothetical protein ESA_02413 [Enterobacter sakazakii
ATCC BAA-894]
gi|156934579 8
9 C. muytjensii ATCC
51329
44 Hypothetical protein ESA_03699 [Enterobacter sakazakii
ATCC BAA-894]
gi|156935823 3
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Page 8 of 13protein is unknown but it would be of significant interest
in future studies since it was not detected in other
strains. Other proteins from Cronobacter and non-Crono-
bacter (E. coli and Salmonella) recognized by the MAbs
were also sequenced and aligned against known protein
sequences deposited in protein sequence banks. It
appeared that most of these proteins are related in terms
of their structure and probably function as most of them
were outer membrane proteins. However, a 42 kDa pro-
tein that was identified in two different Cronobacter spp.
appeared to be different both in structure and function as
o n ea p p e a r e dt ob eaf l a g e l l a rp r o t e i n( Cronobacter
160A), while the second was identified as an outer mem-
brane protein (Cronobacter C 1 3 ) .F u r t h e r ,a ss h o w ni n
Table 2 some of the proteins with the same MW (e.g 35
kDa) were identified in three different bacteria and each
appeared to have a different peptide sequence and conse-
quently different function yet share epitope similarity as
they were all recognized by the same MAb indicating a
similar function too. Interestingly, similar to the 44 kDa
protein, the 35 kDa protein identified in Cronobacter iso-
late number 146A appeared as novel protein and was
termed as a hypothetical protein ESA_02413 with
unknown function. Further, a protein of 40 kDa MW was
identified in Cronobacter isolate number 112 as an outer
membrane protein F which is similar to a protein in
other E. coli as revealed from the protein bank sequence
(Table 2).
Figure 5 Dot blot assay of whole cells of C. muytjensii ATCC 51329 at different concentrations of live or heat-killed. Upper panel, cells
treated with 5% NaOH for 10 s, middle panel cells were treated with 38% HCl for 10 s and lower panel, cells were left untreated. All blots were
probed with MAb 2C2.
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Page 9 of 13Figure 6 Transmission electron micrographs of C. muytjensii ATCC 51329 treated with 0.1 N NaOH A, or 0.1 N HCl B and probed with
MAb 2C2 followed by goat anti-mouse Ig conjugated to 18 nm gold spheres. Magnification × 50,000.
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Page 10 of 13The findings in the current study provide an evidence
of great similarity among Cronobacter spp. and the
other members of Enterobacteriaceae.S u c hf i n d i n g s
were comparable to several previous studies which
reported similar cross reactivity among major OMPs in
Gram negative bacteria and among members of the
Enterobacteriaceae [38-42]. For example, monoclonal
a n t i b o d i e st h a tr e c o g n i z e db u r i e de p i t o p e so ft h eo m p C
from Salmonella typhi were shown to cross react with
porins extracted from 13 species of Enterobacteriaceae
[41]. In addition, it appeared that OMPs extracted from
Cronobacter and non-Cronobacter spp. in this study
shared similar epitopes. This was evident in the multiple
proteins which were recognized by the same MAbs that
appeared to be specific toward the 44 kDa OMP
extracted from the Cronobacter strain used for immuni-
zation. Indeed, these results highlighted the heterogene-
ity of the OMPs in the Cronobacter isolates.
The effect of acid or base treatment on the reactivity of
monoclonal antibodies to their antigens was investigated.
Acid or base treatment increased binding affinity of the
antibodies to Cronobacter cells. This might be due to an
increase in the accessibility of MAbs to the surface pro-
tein antigens due to removal of some extracellular mole-
cules and/or LPS that might have hindered the binding
of MAbs to their target proteins in the case of whole bac-
terial cells. For example, LPS accounts for up to 70% of
the outer monolayer [47]. Indeed, the masking effect of
LPS against binding of antibodies to antigens has been
reported and therefore it can not be under estimated
[48]. These observations were further confirmed by
immunoelectron transmission microscopy (Figure 6).
When live untreated Cronobacter cells were probed with
MAb 2C2, there was no binding to the primary antibo-
dies and hence no gold particle labeling. However, when
Cronobacter cells were treated with NaOH (Figure 6A) or
HCl (Figure 6b), the antibodies appeared to have gained
access to their target represented by increased labeling.
In addition, the MAbs were shown to be bound more
strongly to conformational rather than sequential (linear)
epitopes highlighting the specificity of the MAbs to their
epitopes as appeared in Table 3[41].
Conclusions
To our knowledge, this is the first study that describes
the production of monoclonal antibodies against whole
cells of C. muytjensii with concomitant identification of
the recognized proteins by MALDI-TOF spectrometry.
All MAbs produced in this study were reactive against
the whole cell antigen and Cronobacter OMPs. MAbs
reacted with OMPs of molecular weight ranging between
36 and 49 kDa. However, none of the MAbs showed any
reaction with LPS extracted from Cronobacter. All MAbs
recognized conformational epitopes rather than sequen-
tial as it is evident from the decrease in their binding affi-
nity to fully denatured OMP antigens. Moreover, all
MAbs exhibited a high cross-reactivity against the whole
cell antigen and OMPs from non-Cronobacter. As appar-
e n tf r o mt h eM A L D I - T O Fp r o tein identification, the
overall results indicated that, the major OMPs found in
the Enterobacteriaceae are sufficiently conserved thereby,
promoting antigenic cross-reactivity between genera.
Furthermore, the single-banding pattern and the high
titers obtained in immunoblotting and ELISA for the
Cronobacter strains indicated that the OMPs of closely
related strains are more conserved compared with other
genera evaluated. The results from this study can be of
great help for possible vaccine production against this
pathogen in infants and young children.
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